176 related articles for article (PubMed ID: 27358767)
1. Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma.
Bilello M; Akbari H; Da X; Pisapia JM; Mohan S; Wolf RL; O'Rourke DM; Martinez-Lage M; Davatzikos C
Neuroimage Clin; 2016; 12():34-40. PubMed ID: 27358767
[TBL] [Abstract][Full Text] [Related]
2. MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
Roux A; Roca P; Edjlali M; Sato K; Zanello M; Dezamis E; Gori P; Lion S; Fleury A; Dhermain F; Meder JF; Chrétien F; Lechapt E; Varlet P; Oppenheim C; Pallud J
Radiology; 2019 Dec; 293(3):633-643. PubMed ID: 31592732
[TBL] [Abstract][Full Text] [Related]
3. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL
AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442
[TBL] [Abstract][Full Text] [Related]
4. Probabilistic radiographic atlas of glioblastoma phenotypes.
Ellingson BM; Lai A; Harris RJ; Selfridge JM; Yong WH; Das K; Pope WB; Nghiemphu PL; Vinters HV; Liau LM; Mischel PS; Cloughesy TF
AJNR Am J Neuroradiol; 2013 Mar; 34(3):533-40. PubMed ID: 22997168
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
[TBL] [Abstract][Full Text] [Related]
6. Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.
Fyllingen EH; Bø LE; Reinertsen I; Jakola AS; Sagberg LM; Berntsen EM; Salvesen Ø; Solheim O
Acta Neurochir (Wien); 2021 Jul; 163(7):1895-1905. PubMed ID: 33742279
[TBL] [Abstract][Full Text] [Related]
7. Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab.
Toh CH; Liau CT; Wei KC; Castillo M
J Neurooncol; 2019 Mar; 142(1):149-159. PubMed ID: 30535596
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
9. A series of five population-specific Indian brain templates and atlases spanning ages 6-60 years.
Holla B; Taylor PA; Glen DR; Lee JA; Vaidya N; Mehta UM; Venkatasubramanian G; Pal PK; Saini J; Rao NP; Ahuja CK; Kuriyan R; Krishna M; Basu D; Kalyanram K; Chakrabarti A; Orfanos DP; Barker GJ; Cox RW; Schumann G; Bharath RD; Benegal V
Hum Brain Mapp; 2020 Dec; 41(18):5164-5175. PubMed ID: 32845057
[TBL] [Abstract][Full Text] [Related]
10. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
11. Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.
Fahrendorf D; Hesselmann V; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Heindel W; Bink A
J Neuroimaging; 2015; 25(6):1015-22. PubMed ID: 25703027
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of a Multiparametric Deep Learning Model for Glioblastoma Segmentation Using Heterogeneous Magnetic Resonance Imaging Data From Clinical Routine.
Perkuhn M; Stavrinou P; Thiele F; Shakirin G; Mohan M; Garmpis D; Kabbasch C; Borggrefe J
Invest Radiol; 2018 Nov; 53(11):647-654. PubMed ID: 29863600
[TBL] [Abstract][Full Text] [Related]
13. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.
Macyszyn L; Akbari H; Pisapia JM; Da X; Attiah M; Pigrish V; Bi Y; Pal S; Davuluri RV; Roccograndi L; Dahmane N; Martinez-Lage M; Biros G; Wolf RL; Bilello M; O'Rourke DM; Davatzikos C
Neuro Oncol; 2016 Mar; 18(3):417-25. PubMed ID: 26188015
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
15. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
[TBL] [Abstract][Full Text] [Related]
16. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.
Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL
AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871
[TBL] [Abstract][Full Text] [Related]
17. A novel tool to analyze MRI recurrence patterns in glioblastoma.
Wick W; Stupp R; Beule AC; Bromberg J; Wick A; Ernemann U; Platten M; Marosi C; Mason WP; van den Bent M; Weller M; Rorden C; Karnath HO;
Neuro Oncol; 2008 Dec; 10(6):1019-24. PubMed ID: 18676355
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
Akbari H; Bakas S; Pisapia JM; Nasrallah MP; Rozycki M; Martinez-Lage M; Morrissette JJD; Dahmane N; O'Rourke DM; Davatzikos C
Neuro Oncol; 2018 Jul; 20(8):1068-1079. PubMed ID: 29617843
[TBL] [Abstract][Full Text] [Related]
19. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR
Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
